XyloCor`s XC001 Positive EXACT Phase 2 Data Presented, Published
02 May 2024 //
BUSINESSWIRE
XyloCor hires Reinhardt as CMO to lead gene therapy programs
07 Aug 2019 //
FIERCE BIOTECH
02 May 2024 //
BUSINESSWIRE
07 Aug 2019 //
FIERCE BIOTECH